ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,556.80
      -2.24%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.00%
      Bitcoin
      63,978.80
      0.24%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tonix Pharmaceuticals Holding Corporation (TNXP)

      7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

      TNXP Tonix Pharmaceuticals Holding Corporation

      0.152
      -0.005 (-3.18%)
      Apr 19 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.005 -3.18% 0.152 19:52:47
      Open Price Low Price High Price Close Price Prev Close
      0.1503 0.149 0.163 0.16 0.157
      more quote information »

      Recent News

      Date Time Source Heading
      4/01/202416:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
      3/28/202409:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
      3/25/202408:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
      3/21/202408:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
      3/20/202408:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
      3/19/202408:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
      3/12/202408:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
      3/11/202408:05EDGAR2Form 8-K - Current report
      3/11/202408:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
      3/07/202409:37GLOBENew to The Street Announces TV Episode 560 with its Five..
      3/07/202408:06EDGAR2Form 8-K - Current report
      3/07/202408:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
      3/06/202417:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
      3/06/202408:05EDGAR2Form 8-K - Current report
      3/06/202408:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
      3/05/202408:05EDGAR2Form 8-K - Current report
      3/05/202408:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
      2/29/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202408:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
      2/28/202408:06EDGAR2Form 8-K - Current report
      2/28/202408:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
      2/27/202408:07EDGAR2Form 8-K - Current report
      2/27/202408:00GLOBETonix Pharmaceuticals Announces Positive Results from..
      2/23/202409:30GLOBENew to The Street Announces Line-up of its Corporate..
      2/20/202408:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
      2/16/202409:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
      2/15/202417:02EDGAR2Form 8-K - Current report
      2/14/202415:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/14/202408:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
      2/13/202408:05EDGAR2Form 8-K - Current report
      2/13/202408:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
      2/12/202408:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
      2/12/202407:06EDGAR2Form 8-K - Current report
      1/31/202407:05EDGAR2Form 8-K - Current report
      1/31/202407:00GLOBETonix Pharmaceuticals Announces Research Indicating..
      1/29/202407:00EDGAR2Form 8-K - Current report
      1/29/202407:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
      1/25/202416:08EDGAR2Form 8-K - Current report
      1/25/202407:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
      1/19/202416:31EDGAR2Form 8-K - Current report
      1/11/202416:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/09/202407:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
      1/08/202417:07EDGAR2Form 8-K - Current report
      1/08/202416:33EDGAR2Form DEF 14A - Other definitive proxy statements
      1/03/202416:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/03/202407:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
      1/02/202416:15EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      TNXP
      Tonix Pharmaceuticals
      Delayed Upgrade Clock